Bertsias A, Avgoustidis N, Papalopoulos I, Repa A, et al. Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study. Arthritis Res Ther 2022;24:132.
PMID: 35655317